Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy-Reference-Cited by-同舟云学术

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy

Published:2018-08-31 Issue:10 Volume:93 Page:E342-E345
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Racil Zdenek¹^ORCID,Koritakova Eva²³,Sacha Tomasz⁴^ORCID,Klamova Hana⁵,Belohlavkova Petra⁶,Faber Edgar⁷,Rea Delphine⁸,Malaskova Ludmila⁹,Prochazkova Jirina¹,Zackova Daniela¹,Voglova Jaroslava⁶,Wącław Joanna⁴,Cetkovsky Petr⁵,Zak Pavel⁶,Mayer Jiri¹

Affiliation:

1. Department of Internal Medicine, Hematology and Oncology; Masaryk University and University Hospital Brno; Brno Czech Republic

2. Faculty of Medicine, Institute of Biostatistics and Analyses; Masaryk University; Brno Czech Republic

3. Institute of Biostatistics and Analyses, Ltd.; Brno Czech Republic

4. Department of Hematology; Jagiellonian University Hospital; Kraków Poland

5. Institute of Hematology and Blood Transfusion and 1st Faculty of Medicine of the Charles University; Prague Czech Republic

6. 4th Department of Internal Medicine - Hematology; University Hospital Hradec Kralove; Hradec Kralove Czech Republic

7. Department of Hemato-Oncology; University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University; Olomouc Czech Republic

8. Department of Adult Hematology and INSERM-UMR 1160, Hôpital Saint-Louis, APHP; Paris France

9. Department of Clinical Biochemistry; University Hospital Brno; Brno Czech Republic

Funder

Bristol-Myers Squibb

Ministerstvo Zdravotnictví Ceské Republiky

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25232/fullpdf

Reference6 articles.

1. Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin;Ito;Int J Hematol,2013

2. Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia;Racil;Haematologica,2013

3. Correct homeostasis model assessment (HOMA) evaluation uses the computer program;Levy;Diabetes Care,1998

4. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures;Gutt;Diabetes Res Clin Pract,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes;Expert Review of Hematology;2024-07-26

2. Ischaemic heart disease in patients with cancer;European Heart Journal;2024-02-07

3. Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia;Internal Medicine;2024

4. The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia;Hemato;2023-07-14

5. Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia;American Journal of Physiology-Endocrinology and Metabolism;2023-03-01